G1 Therapeutics Current Ratio | GTHX

Annual Current Ratio G1 Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.41	1.58	2.3	4.46	9.72	29.8	8.93	8.57	11	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
29.8	1.41	8.65

Quarterly Current Ratio G1 Therapeutics

2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.33	1.37	1.41	1.48	1.64	1.38	1.58	1.38	1.55	1.85	2.3	3.74	4.35	4.89	4.46	4.25	5.1	9.48	9.72	10.2	17.5	27.6	29.8	28.6	13.5	15.6	8.93	10.2	11.4	8.93	8.57	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
29.8	1.33	8.19

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
AbbVie ABBV	3.18	$ 263.04	0.49 %	$ 465 B	USA
AbCellera Biologics ABCL	3.48	$ 11.41	2.15 %	$ 3.41 B	Canada
Фармсинтез LIFE	0.454	-	-	-	Russia
Aclaris Therapeutics ACRS	2.8	$ 5.53	6.02 %	$ 678 M	USA
ADC Therapeutics SA ADCT	0.635	$ 1.09	3.74 %	$ 139 M	Schweiz
Amryt Pharma plc AMYT	1.78	-	-	$ 621 M	Britain
Evelo Biosciences EVLO	0.928	-	-14.46 %	$ 27.9 M	USA
Allakos ALLK	5.43	-	-	$ 28.6 M	USA
Checkmate Pharmaceuticals CMPI	8.41	-	-	$ 231 M	USA
Clovis Oncology CLVS	0.629	-	-7.23 %	$ 13 M	USA
Chimerix CMRX	6	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	3.11	-	-	$ 401 M	USA
ADMA Biologics ADMA	4.25	$ 8.61	0.16 %	$ 2.05 B	USA
Eiger BioPharmaceuticals EIGR	0.729	-	-9.21 %	$ 2.55 M	USA
89bio ETNB	6.15	-	-	$ 1.55 B	USA
Freeline Therapeutics Holdings plc FRLN	2.53	-	-	$ 384 M	Britain
Fusion Pharmaceuticals FUSN	4.51	-	-	$ 1.41 B	Canada
Guardion Health Sciences GHSI	3.16	-	-0.31 %	$ 3.64 M	USA
Genocea Biosciences GNCA	1.94	-	-15.0 %	$ 3.04 M	USA
Gritstone Oncology GRTS	1.41	-	0.42 %	$ 213 M	USA
Harpoon Therapeutics HARP	1.08	-	-	$ 763 M	USA
Humanigen HGEN	0.193	-	-81.12 %	$ 4.28 M	USA
HOOKIPA Pharma HOOK	2.63	-	-6.92 %	$ 79.4 M	USA
Intercept Pharmaceuticals ICPT	1.2	-	-	$ 643 M	USA
IGM Biosciences IGMS	1.22	-	-	$ 76.9 M	USA
IMV IMV	0.826	-	-	$ 13.1 M	Canada
Intra-Cellular Therapies ITCI	6.26	-	-	$ 13.6 B	USA
Kinnate Biopharma KNTE	12.2	-	-	$ 123 M	USA
Chinook Therapeutics KDNY	4.34	-	-	$ 2.6 B	USA
Kaleido Biosciences KLDO	1.27	-	-3.69 %	$ 12.4 M	USA
Kronos Bio KRON	3.38	-	1.49 %	$ 50.8 M	USA
Karuna Therapeutics KRTX	16.3	-	-	$ 12.2 B	USA
Landos Biopharma LABP	6.09	-	0.58 %	$ 144 M	USA
La Jolla Pharmaceutical Company LJPC	0.603	-	-	$ 154 M	USA
LogicBio Therapeutics LOGC	1.96	-	-	$ 229 M	USA
Lumos Pharma LUMO	3.05	-	-	$ 35.3 M	USA
Merrimack Pharmaceuticals MACK	43.5	-	-	$ 216 M	USA
Stealth BioTherapeutics Corp MITO	0.526	-	-	$ 23.9 M	USA
Mirati Therapeutics MRTX	5.83	-	-	$ 3.3 B	USA
NexImmune NEXI	1.69	-	70.13 %	$ 4.12 M	USA
9 Meters Biopharma NMTR	1.08	-	-42.97 %	$ 1.05 M	USA
InVivo Therapeutics Holdings Corp. NVIV	6.12	-	-37.48 %	$ 476 K	USA
Nymox Pharmaceutical Corporation NYMX	0.088	-	-19.68 %	$ 18.4 M	Canada
ObsEva SA OBSV	1.7	-	-15.52 %	$ 10.5 M	Schweiz
Oncorus ONCR	1.71	-	-8.54 %	$ 3.19 M	USA
OncoSec Medical Incorporated ONCS	1.39	-	31.87 %	$ 1.61 M	USA
Oncternal Therapeutics ONCT	5.5	-	-24.12 %	$ 1.56 M	USA
Opiant Pharmaceuticals OPNT	2.99	-	-	$ 109 M	USA
Orchard Therapeutics plc ORTX	1.81	-	1.02 %	$ 90.8 M	Britain